We are live on ! Find out more
PLSE icon

Pulse Biosciences
PLSE

47 hedge funds and large institutions have $20.5M invested in Pulse Biosciences in 2018 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 12 increasing their positions, 13 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

155% more call options, than puts

Call options by funds: $680K | Put options by funds: $267K

8% less repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 13

2.21% less ownership

Funds ownership: 11.2% → 8.99% (-2.2%)

6% less funds holding

Funds holding: 50 → 47 (-3)

30% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 10

53% less capital invested

Capital invested by funds: $43.2M → $20.5M (-$22.7M)

Holders
47
Holders Change
-3
Holders Change %
-6%
% of All Funds
1.08%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
12
Reduced
13
Closed
10
Calls
$680K
Puts
$267K
Net Calls
+$413K
Net Calls Change
+$2.24M

Top Buyers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$546K
2
WIM
Westside Investment Management
California
+$290K
3
VF
Virtu Financial
New York
+$220K
4
Wolverine Trading
Wolverine Trading
Illinois
+$197K
5
Vanguard Group
Vanguard Group
Pennsylvania
+$128K

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$5.81M
2
TAM
Tocqueville Asset Management
New York
-$507K
3
Millennium Management
Millennium Management
New York
-$290K
4
Brown Advisory
Brown Advisory
Maryland
-$248K
5
FC
Fore Capital
New York
-$236K
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of Montreal
26
Bank of Montreal
Ontario, Canada
$95K – – –
AIG
27
American International Group
New York
$79K -$5.94K -313 -5%
SPIA
28
Steward Partners Investment Advisory
New York
$49K +$19K +1,000 +38%
PCM
29
Prelude Capital Management
New York
$45K +$63.4K +3,340 New
AG
30
Advisor Group
Arizona
$36K – – –
Bank of America
31
Bank of America
North Carolina
$29K +$19.4K +1,020 +86%
BNP Paribas Financial Markets
32
BNP Paribas Financial Markets
France
$29K +$2.28K +120 +6%
JP Morgan Chase
33
JP Morgan Chase
New York
$25K -$2.47K -130 -7%
Barclays
34
Barclays
United Kingdom
$25K +$8.6K +453 +31%
Legal & General Group
35
Legal & General Group
United Kingdom
$24K -$11K -578 -25%
ECM
36
Exchange Capital Management
Michigan
$24K – – –
IWM
37
IHT Wealth Management
Illinois
$16K – – –
Fifth Third Bancorp
38
Fifth Third Bancorp
Ohio
$14K – – –
AIM
39
Assured Investment Management
New York
$12K +$16.7K +879 New
AIP
40
Ameritas Investment Partners
Nebraska
$11K – – –
CG
41
Cutler Group
California
$9K – – –
Manulife (Manufacturers Life Insurance)
42
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$6K -$130K -6,858 -94%
PNC Financial Services Group
43
PNC Financial Services Group
Pennsylvania
$4K – – –
WOC
44
West Oak Capital
California
$1.35K +$1.9K +100 New
Citigroup
45
Citigroup
New York
$1K -$1.94K -102 -70%
Royal Bank of Canada
46
Royal Bank of Canada
Ontario, Canada
$1K -$1.82K -96 -49%
TAM
47
Tocqueville Asset Management
New York
– -$507K -21,500 Closed
Millennium Management
48
Millennium Management
New York
– -$290K -12,272 Closed
Brown Advisory
49
Brown Advisory
Maryland
– -$248K -10,500 Closed
FC
50
Fore Capital
New York
– -$236K -10,000 Closed
1
2
3

PLSE Hedge Fund Activity: Q1 2018 in Review

47 of the 4,364 institutional investors tracked by Wall St. Rank reported a position in Pulse Biosciences (PLSE) for Q1 2018, worth a combined $20.5M — down 53% from $43.2M a quarter earlier.

Sellers outnumbered buyers: 10 funds closed out of PLSE and 7 opened new positions — a net loss of 3 holders — while 13 trimmed existing stakes and 12 added.

The largest buyer was Susquehanna International Group, opening a new position worth an estimated $546K. The largest seller was Citadel Advisors, cutting an estimated $5.81M.

  • 47 institutional investors held Pulse Biosciences (PLSE) as of Q1 2018, down from 50 in Q4 2017.
  • Funds reported $20.5M of Pulse Biosciences stock for Q1 2018, down 53% quarter-over-quarter.
  • 7 funds opened new Pulse Biosciences positions in Q1 2018 and 10 closed out, a net change of -3 holders.
  • The largest Pulse Biosciences buyer in Q1 2018 was Susquehanna International Group, an estimated $546K added.
  • The largest Pulse Biosciences seller in Q1 2018 was Citadel Advisors, an estimated $5.81M sold.

Based on aggregated 13F filings for Q1 2018.